36 MONTHS PANGAEA: A 5-YEAR NON-INTERVENTIONAL STUDY OF SAFETY, EFFICACY AND PHARMACOECONOMIC DATA FOR FINGOLIMOD PATIENTS IN DAILY CLINICAL PRACTICE

被引：9
|
作者：
Ziemssen, T. [1 ]
Albrecht, H. [2 ]
Haas, J. [3 ]
Klotz, L. [4 ]
Lang, M. [5 ]
Lassek, C. [6 ]
Schmidt, S. [7 ]
Tackenberg, B. [8 ]
Cornelissen, C. [9 ]
机构：
[1] Univ Clin Carl Gustav Carus, Dresden, Germany
[2] Praxis Neurol Munchen, Munich, Germany
[3] Jud Krankenhaus Berlin, Berlin, Germany
[4] Uniklin Munster, Munster, Germany
[5] NTD Study Grp, Ulm, Germany
[6] Neurol Gemeinschaftspraxis Kassel & Veilmar, Kassel, Germany
[7] NTD Study Grp, Bonn, Germany
[8] Philipps Univ Giessen & Marburg, Marburg, Germany
[9] Novartis Pharma GmbH, Nurnberg, Germany
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2894
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND2
引用
收藏
页码：A749 / A749
页数：1
相关论文
共 50 条
  • [1] 36 months PANGAEA: a 5-year non-interventional study of safety, efficacy and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 281 - 282
  • [2] 36 months PANGAEA: A 5-year non-interventional study of safety, efficacy and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Albrecht, H.
    Klotz, L.
    Schmidt, S.
    Schwarz, H. -J.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 28 - 28
  • [3] 36 months PANGAEA-A 5-year non-interventional study of safety, efficacy, and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L. Luisa
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP19 - NP20
  • [4] 24 month PANGAEA: a 5-year non-interventional study of safety, efficacy and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Fuchs, A.
    Schwarz, H-J
    van Lokven, T.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 115 - 116
  • [5] 4 Years PANGAEA: A 5-Year Non-Interventional Study of Safety, Effectiveness and Pharmacoeconomic Data for Fingolimod Patients in Daily Clinical Practice - Effectiveness Update
    Cornelissen, Christian
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Ziemssen, Tjalf
    NEUROLOGY, 2016, 86
  • [6] 4 years PANGAEA: A 5-year non-interventional study of safety, effectiveness and pharmacoeconomic data for fingolimod patients in daily clinical practice - effectiveness update
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 417 - 417
  • [7] 4 Years Safety of Fingolimod in Real World: PANGAEA a Non-Interventional Study of Safety, Effectiveness and Pharmacoeconomic is Data for Fingolimod Patients in Daily Clinical Practice
    Ziemssen, Tjalf
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Cornelissen, Christian
    NEUROLOGY, 2016, 86
  • [8] 4 years safety of fingolimod in real world: PANGAEA, a non-interventional study of safety, effectiveness and pharmacoeconomic data for fingolimod patients in daily clinical practice
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 416 - 416
  • [9] 5 years effectiveness of fingolimod in daily clinical practice: results of the non-interventional study PANGAEA
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 372 - 373
  • [10] 5 years safety of fingolimod in real world: First results from PANGAEA, a non-interventional study of RRMS patients treated with fingolimod, on safety and adherence after 5 years of fingolimod in daily clinical practice
    Ziemssen, Tjalf
    Albrecht, Holger
    Haas, Judith
    Klotz, Luisa
    Lang, Michael
    Lassek, Chrstoph
    Schmidt, Stephan
    Tackenberg, Bjorn
    Cornelissen, Christian
    NEUROLOGY, 2017, 88
12345